ArticleAntimicrobial agents and chemotherapy2017
Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
Erratum issuedOpen access · bronzeAbstract read
In one paragraph
Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 105 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
105 citing papers in PubMed, 1 synthesis or guideline pooled it, 170 citations in OpenAlex.
- Prevalence of colistin resistance in clinical isolates ofFrontiers in microbiology · 2024Pooled it
- Multidrug resistant Pseudomonas aeruginosa in Estonian hospitals.BMC infectious diseases · 2018Trial
- Distinct proteomic profiles of clinical isolates show diversity of Pseudomonas aeruginosa colistin-resistance.Clinical proteomics · 2026Article
- AMR-GNN: a multi-representation graph neural network framework to enable genomic antimicrobial resistance prediction.Nature communications · 2026Article
- Epidemiological insights into Haemophilus influenzae and Pseudomonas aeruginosa persistent colonization in non-cystic fibrosis bronchiectasis patients: a longitudinal and multicenter study.Respiratory research · 2026Article
- Defence systems drive accessory genome interactions inISME communications · 2026Article
- Article
- Comparative Genomic Analysis ofInfection and drug resistance · 2026Article
- Adaptive evolution ofMicrobial genomics · 2026Article
- Metallo-β-lactamase-producingFrontiers in microbiology · 2026Review
- First nationwide survey onAntimicrobial agents and chemotherapy · 2025Article
- Cefiderocol Resistance inAntibiotics (Basel, Switzerland) · 2025Article
- CombattingAntibiotics (Basel, Switzerland) · 2025Review
- Rapid prediction of carbapenemases inJournal of clinical microbiology · 2025Article
- Addressing carbapenemase-producing extensively drug-resistant Pseudomonas aeruginosa: the potential of cefiderocol and ceftazidime/avibactam plus aztreonam therapy.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025Article
- Effects of different mechanisms on antimicrobial resistance inMicrobiology spectrum · 2025Article
- Antibiotic Resistance and Virulence Determinants ofMicroorganisms · 2025Article
- Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant Pseudomonas aeruginosa Bacteremia or Pneumonia.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025Article
- Ceftazidime-avibactam activity againstIranian journal of microbiology · 2025Article
- Interplay between porin deficiency, fitness, and virulence in carbapenem-non-susceptible Pseudomonas aeruginosa and Enterobacteriaceae.PLoS pathogens · 2025Review
45 more citing papers are in PubMed but not listed here.
Corrections and comments
- Erratum issued
Authors and funding
25 authors at 10 institutions in 1 country.
Ester Del Barrio-TofiñoDepartment of Microbiology, Intensive Care Unit and Unidad de Investigación, Hospital Universitari Son Espases, Instituto de Investigación Illes Balears (IdISBa), Palma de Mallorca, Spain.
Carla López-CausapéDepartment of Microbiology, Intensive Care Unit and Unidad de Investigación, Hospital Universitari Son Espases, Instituto de Investigación Illes Balears (IdISBa), Palma de Mallorca, Spain.
Gabriel CabotDepartment of Microbiology, Intensive Care Unit and Unidad de Investigación, Hospital Universitari Son Espases, Instituto de Investigación Illes Balears (IdISBa), Palma de Mallorca, Spain.ORCID 0000-0002-6452-9945
Alba RiveraDepartment of Microbiology and Infectious Diseases, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Natividad BenitoDepartment of Microbiology and Infectious Diseases, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Concepción SeguraLaboratory de Referència de Catalunya and Department of Infectious Diseases, Hospital del Mar, Infectious Pathology and Antimicrobial Research Group (IPAR)-Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.
María Milagro MonteroLaboratory de Referència de Catalunya and Department of Infectious Diseases, Hospital del Mar, Infectious Pathology and Antimicrobial Research Group (IPAR)-Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.
Luisa SorlíLaboratory de Referència de Catalunya and Department of Infectious Diseases, Hospital del Mar, Infectious Pathology and Antimicrobial Research Group (IPAR)-Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.
Fe TubauDepartment of Microbiology and Infectious Diseases, Hospital Universitari de Bellvitge, Barcelona, Spain.
Silvia Gómez-ZorrillaDepartment of Microbiology and Infectious Diseases, Hospital Universitari de Bellvitge, Barcelona, Spain.
Nuria TormoDepartment of Microbiology and Infectious Diseases, Consorcio Hospital General Universitario de Valencia, Valencia, Spain.
Raquel Durá-NavarroDepartment of Microbiology and Infectious Diseases, Consorcio Hospital General Universitario de Valencia, Valencia, Spain.
Esther ViedmaDepartment of Microbiology and Infectious Diseases, Hospital Universitario 12 de Octubre, Madrid, Spain.
Elena Resino-FozDepartment of Microbiology and Infectious Diseases, Hospital Universitario 12 de Octubre, Madrid, Spain.
Marta Fernández-MartínezDepartment of Microbiology and Infectious Diseases, Hospital Universitario Marqués de Valdecilla, Instituto de Investigacion Valdecilla (IDIVAL), Santander, Spain.
Claudia González-RicoDepartment of Microbiology and Infectious Diseases, Hospital Universitario Marqués de Valdecilla, Instituto de Investigacion Valdecilla (IDIVAL), Santander, Spain.
Izaskun Alejo-CanchoDepartment of Microbiology and Infectious Diseases, Hospital Universitari Clínic, Barcelona, Spain.
Jose Antonio MartínezDepartment of Microbiology and Infectious Diseases, Hospital Universitari Clínic, Barcelona, Spain.
Cristina Labayru-EchverriaDepartment of Microbiology and Infectious Diseases, Hospital Universitario de Burgos, Burgos, Spain.
Carlos DueñasDepartment of Microbiology and Infectious Diseases, Hospital Universitario de Burgos, Burgos, Spain.
Ignacio AyestaránDepartment of Microbiology, Intensive Care Unit and Unidad de Investigación, Hospital Universitari Son Espases, Instituto de Investigación Illes Balears (IdISBa), Palma de Mallorca, Spain.
Laura ZamoranoDepartment of Microbiology, Intensive Care Unit and Unidad de Investigación, Hospital Universitari Son Espases, Instituto de Investigación Illes Balears (IdISBa), Palma de Mallorca, Spain.
Luis Martinez-MartinezUnit of Microbiology, Hospital Universitario Reina Sofía, Departament of Microbiology, University of Córdoba, Córdoba, Spain.
Juan Pablo HorcajadaLaboratory de Referència de Catalunya and Department of Infectious Diseases, Hospital del Mar, Infectious Pathology and Antimicrobial Research Group (IPAR)-Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.
Antonio OliverDepartment of Microbiology, Intensive Care Unit and Unidad de Investigación, Hospital Universitari Son Espases, Instituto de Investigación Illes Balears (IdISBa), Palma de Mallorca, Spain antonio.oliver@ssib.es.ORCID 0000-0001-9327-1894
Health Research Institute of the Balearic Islands · ESHospital del Mar Research Institute · ESBellvitge University Hospital · ESHospital de Sant Pau · ESHospital General Universitario De Valencia · ESHospital Universitari de Vic · ESHospital Universitario 12 De Octubre · ESHospital Universitario de Burgos · ESInstituto de Investigación Marqués de Valdecilla · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ES
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study assessed the molecular epidemiology, resistance mechanisms, and susceptibility profiles of a collection of 150 extensively drug-resistant (XDR)
Indexed as
AminoglycosidesAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasesbeta-Lactam ResistanceCephalosporinsDrug Resistance, BacterialFluoroquinolonesHumansMicrobial Sensitivity TestsMolecular EpidemiologyPenicillanic AcidPolymyxinsPseudomonas aeruginosaPseudomonas InfectionsSpainAminoglycosidesAmpC beta-lactamasesAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasesceftolozane, tazobactam drug combinationCephalosporinsFluoroquinolonesPenicillanic AcidPolymyxinsTazobactamextensively drug resistanthigh-risk clonesPseudomonas aeruginosawhole-genome sequencing
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.